Justin A. Green

2.6k total citations
28 papers, 1.2k citations indexed

About

Justin A. Green is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Oncology. According to data from OpenAlex, Justin A. Green has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 8 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Justin A. Green's work include Malaria Research and Control (12 papers), Infectious Diseases and Tuberculosis (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Justin A. Green is often cited by papers focused on Malaria Research and Control (12 papers), Infectious Diseases and Tuberculosis (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Justin A. Green collaborates with scholars based in United Kingdom, United States and Switzerland. Justin A. Green's co-authors include Jon S. Friedland, Paul Elkington, Stephan Duparc, Ronnatrai Rueangweerayut, Brenda Ang, Nick Carter, Li Yang Hsu, Nicholas I. Paton, Jorge Villacian and Lawrence Lee and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Justin A. Green

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Justin A. Green

Since Specialization

Citations

This map shows the geographic impact of Justin A. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin A. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin A. Green more than expected).

Fields of papers citing papers by Justin A. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin A. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin A. Green. The network helps show where Justin A. Green may publish in the future.

Co-authorship network of co-authors of Justin A. Green

This figure shows the co-authorship network connecting the top 25 collaborators of Justin A. Green. A scholar is included among the top collaborators of Justin A. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin A. Green. Justin A. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis 2022 ·eLife ·James A Watson, Robert J. Commons, Joel Tärning, J. A. Simpson, Alejandro Llanos‐Cuentas, Marcus Lacerda, Justin A. Green, Gavin Koh, Cindy S. Chu, François Nosten, Ric N. Price, Nicholas Day, Nicholas J. White	15
2	A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study 2022 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Ana Belén Barragán Martín, Justin A. Green, Stephan Duparc, Katie Rolfe, (unknown), Lionel Tan, Navin Goyal	8
3	Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial 2021 ·The Lancet Child & Adolescent Health ·Iván Darío Vélez, Tran Tinh Hien, Justin A. Green, (unknown), (unknown), (unknown), John Breton, Terry B. Ernest, Katie Rolfe, Maxine Taylor, Khadeeja Mohamed, (unknown), Nguyễn Hoàng Châu, (unknown), Stephan Duparc, Lionel Tan, Navin Goyal	7
4	Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria 2020 ·Pharmacogenetics and Genomics ·Pamela L. St. Jean, Gavin Koh, John Breton, Fe Esperanza Espino, Tran Tinh Hien, Srivicha Krudsood, Marcus Lacerda, Alejandro Llanos‐Cuentas, Chanthap Lon, Rezika Mohammed, (unknown), Dhélio B. Pereira, David Saunders, Iván Darío Vélez, Daniel Yilma, (unknown), Stephan Duparc, Justin A. Green	7
5	Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers 2017 ·American Journal of Tropical Medicine and Hygiene ·Ronnatrai Rueangweerayut, Germana Bancone, (unknown), Andrew P. Beelen, (unknown), Jörg J. Möhrle, (unknown), Khadeeja Mohamed, (unknown), Sushma Narayan, (unknown), Ann K. Miller, François Nosten, Lucio Luzzatto, Stephan Duparc, Jőrg‐Peter Kleim, Justin A. Green	72
6	A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria 2017 ·PLoS ONE ·Mark M. Fukuda, Srivicha Krudsood, Khadeeja Mohamed, Justin A. Green, (unknown), Harald Noedl, (unknown), Mali Ittiverakul, Nillawan Buathong, Sabaithip Sriwichai, R. Scott Miller, Colin Ohrt	26
7	Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial 2016 ·Malaria Journal ·Pamela L. St. Jean, Zhengyu Xue, Nick Carter, Gavin Koh, Stephan Duparc, Maxine Taylor, Claire Beaumont, Alejandro Llanos‐Cuentas, Ronnatrai Rueangweerayut, Srivicha Krudsood, Justin A. Green, Justin P. Rubio	61
8	Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping 2015 ·The Journal of Infectious Diseases ·Hans‐Peter Beck, Rahel Wampfler, Nick Carter, Gavin Koh, Lyda Osório, Ronnatrai Rueangweerayut, (unknown), Marcus Lacerda, Alejandro Llanos‐Cuentas, Stephan Duparc, Justin P. Rubio, Justin A. Green	23
9	Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria 2015 ·Antimicrobial Agents and Chemotherapy ·David M. Tenero, Justin A. Green, Navin Goyal	11
10	Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study 2013 ·The Lancet ·Alejandro Llanos‐Cuentas, Marcus Lacerda, Ronnatrai Rueangweerayut, Srivicha Krudsood, Sandeep K. Gupta, Sanjay Kumar Kochar, Preetam Arthur, (unknown), Jörg J. Möhrle, Stephan Duparc, (unknown), Jőrg‐Peter Kleim, Nick Carter, Justin A. Green, (unknown)	180
11	In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathway 2013 ·Journal of Neuroinflammation ·Justin A. Green, Lucinda Rand, Rachel Moores, (unknown), Theodore Pezas, Paul Elkington, Jon S. Friedland	7
12	Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways 2011 ·Journal of Neuroinflammation ·Justin A. Green, (unknown), Karolina Janczar, Ong C, Rachel Moores, (unknown), Paul Elkington, Federico Roncaroli, Jon S. Friedland	29
13	Both CD31⁺and CD31⁻Naive CD4⁺T Cells Are Persistent HIV Type 1–Infected Reservoirs in Individuals Receiving Antiretroviral Therapy 2010 ·The Journal of Infectious Diseases ·Fiona Wightman, Ajantha Solomon, Gabriela Khoury, Justin A. Green, Lachlan Gray, Paul R. Gorry, Yung Shwen Ho, Nitin K. Saksena, Jennifer Hoy, Suzanne M. Crowe, Paul Cameron, Sharon R. Lewin	94
14	Mycobacterium tuberculosis Upregulates Microglial Matrix Metalloproteinase-1 and -3 Expression and Secretion via NF-κB– and Activator Protein-1–Dependent Monocyte Networks 2010 ·The Journal of Immunology ·Justin A. Green, Paul Elkington, Caroline J. Pennington, Federico Roncaroli, (unknown), Rachel Moores, Anwen Bullen, Joanna C. Porter, Dan Agranoff, Dylan R. Edwards, Jon S. Friedland	59
15	Matrix Metalloproteinase-1 Is Regulated in Tuberculosis by a p38 MAPK-Dependent, p -Aminosalicylic Acid-Sensitive Signaling Cascade 2009 ·The Journal of Immunology ·Lucinda Rand, Justin A. Green, Luísa Saraiva, Jon S. Friedland, Paul Elkington	43
16	Analysis of Matrix Metalloproteinase Secretion by Macrophages 2009 ·Methods in molecular biology ·Paul Elkington, Justin A. Green, Jon S. Friedland	42
17	Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis 2009 ·PLoS ONE ·Justin A. Green, (unknown), Jeremy Farrar, (unknown), Phu Hung Nguyen, (unknown), (unknown), (unknown), Hien Tran, Jon S. Friedland, Guy Thwaites	59
18	Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo 2007 ·The Journal of Immunology ·James Harris, Robert K. Nuttall, Paul Elkington, Justin A. Green, Donna Horncastle, Manuel B. Graeber, Dylan R. Edwards, Jon S. Friedland	45
19	Synergistic Up-Regulation of Epithelial Cell Matrix Metalloproteinase-9 Secretion in Tuberculosis 2007 ·American Journal of Respiratory Cell and Molecular Biology ·Paul Elkington, Justin A. Green, Jenny E. Emerson, (unknown), Joseph J. Boyle, Cecilia O’Kane, Jon S. Friedland	63
20	Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts 2003 ·Emerging infectious diseases ·Li Yang Hsu, (unknown), Justin A. Green, Brenda Ang, Nicholas I. Paton, Lawrence Lee, Jorge Villacian, P.L. Lim, Arul Earnest, Yee‐Sin Leo	218

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact